Table 2.
Multivariable analysis of predictors of intermediate–high cardiovascular risk in patients with IBD.
| Variable | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | P |
|---|---|---|---|
| NAFLD (yes vs no) | 3.25 (2.04–5.18) | 2.97 (1.56–5.68) | .001 |
| Liver fibrosis (yes vs no) | 2.37 (1.16–4.82) | 1.06 (0.25–4.55) | .936 |
| BMI (per kg m−2) | 1.04 (0.99–1.09) | 1.00 (0.93–1.06) | .875 |
| Ulcerative colitis (yes vs no) | 1.72 (1.08–2.74) | 2.32 (1.35–3.98) | .002 |
| IBD duration (per 10 years) | 1.45 (1.18–1.79) | 1.55 (1.22–1.97) | <.001 |
| Active IBD (yes vs no) | 0.72 (0.42–1.23) | 0.64 (0.35–1.17) | .145 |
| NAFLD × Fibrosis | — | 1.68 (0.27–10.32) | .576 |
Odds ratios (OR) and 95% CIs are shown for each variable analyzed in univariable and multivariable logistic regression analysis. Abbreviations: BMI, body mass index; IBD, inflammatory bowel disease; NAFLD, nonalcoholic fatty liver disease.